AbbVie Inc.
ABBV
$146.28
-$1.12-0.76%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 14.81B | 14.58B | 13.54B | 14.89B | 14.34B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.81B | 14.58B | 13.54B | 14.89B | 14.34B |
| Cost of Revenue | 5.00B | 4.14B | 4.02B | 4.28B | 4.34B |
| Gross Profit | 9.81B | 10.44B | 9.52B | 10.61B | 10.00B |
| SG&A Expenses | 3.17B | 3.09B | 2.81B | 3.14B | 2.95B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 68.00M | 500.00M |
| Total Operating Expenses | 9.78B | 8.85B | 8.32B | 9.30B | 9.43B |
| Operating Income | 5.03B | 5.74B | 5.22B | 5.59B | 4.91B |
| Income Before Tax | 4.40B | 1.18B | 4.93B | 4.27B | 3.69B |
| Income Tax Expenses | 448.00M | 255.00M | 436.00M | 226.00M | 508.00M |
| Earnings from Continuing Operations | 3.95B | 928.00M | 4.49B | 4.05B | 3.18B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.00M | -4.00M | -3.00M | -1.00M | -1.00M |
| Net Income | 3.95B | 924.00M | 4.49B | 4.04B | 3.18B |
| EBIT | 5.03B | 5.74B | 5.22B | 5.59B | 4.91B |
| EBITDA | 7.24B | 7.79B | 7.27B | 7.57B | 7.04B |
| EPS Basic | 2.22 | 0.52 | 2.53 | 2.26 | 1.78 |
| Normalized Basic EPS | 1.61 | 1.83 | 1.64 | 1.75 | 1.54 |
| EPS Diluted | 2.21 | 0.51 | 2.52 | 2.26 | 1.78 |
| Normalized Diluted EPS | 1.61 | 1.82 | 1.63 | 1.75 | 1.53 |
| Average Basic Shares Outstanding | 1.77B | 1.77B | 1.77B | 1.78B | 1.77B |
| Average Diluted Shares Outstanding | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B |
| Dividend Per Share | 1.41 | 1.41 | 1.41 | 1.41 | 1.30 |
| Payout Ratio | 63.41% | 271.32% | 56.26% | 57.22% | 72.82% |
